Nashville hosted the first annual conference of the Academic Drug Discovery Consortium It’s become a familiar story in biopharma, as...

With several IPO hopefuls now in registration and a very odd venture round raised by a San Diego biotech, there was plenty of financing n...

The big funding news this fortnight doesn’t come from public or private investors, it comes from taxpayers. As " The Pink Sheet ...

"Partner of choice" is a cliche in the biopharma business development world, but the US National Institutes of Health is trying to...

Francis Collins will be named NIH Director, according to sources familiar with the process. Picking Collins gives the Obama Administration s...

Yet another prominent academic is being replaced as a psychiatry department chair and the move coincides with an investigation by the U.S. S...

I just tweeted this but for the people not on my twitter feed, Rick Lifton is being strongly considered as head of NIH.  Lifton is Chairman ...

Novartis isn't taking any chances about missing the last call from the government's cash spigot for vaccine manufacturers. The Swiss...

If you thought the battle over Lucentis and Avastin was confined to FDA, CMS and NIH, you’re wrong. Now Congress is jumping into the fray in...